SpyGlass Pharma SGP
NASDAQ SGP
$26.27 +0.27 (+1.04%)
As of: Oct 1, 2026 · 3:30 PM EDT

SpyGlass Pharma (SGP) Income from Continuing Operations (2025 - 2026)

Updated

SpyGlass Pharma (SGP) posted Income from Continuing Operations of -$19.86 million for Q2 2026, compared with -$8.68 million a year earlier.

Analysis

SpyGlass Pharma (SGP) Income from Continuing Operations (2025 - 2026) Analysis & Trends

For FY2025, SpyGlass Pharma's Income from Continuing Operations came in at -$39.87 million.

  • In prior years, SpyGlass Pharma's Income from Continuing Operations was -$29.16 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.28 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -246.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 SpyGlass Pharma 869.60 Mn 869.60 Mn - -19.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -19.86 Mn
Jun 30, 2025 -8.68 Mn
API Access

SpyGlass Pharma Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=SGP&period=max&api_key=YOUR_API_KEY